The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...
New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback